Page last updated: 2024-09-03

bw 373u86 and Cardiovascular Stroke

bw 373u86 has been researched along with Cardiovascular Stroke in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Donner, D; du Toit, EF; Headrick, JP; Peart, JN1
Fryer, RM; Gross, GJ; Hsu, AK; Ludwig, LM; Patel, HH; Warltier, DC1
Bolli, R; Kodani, E; Shinmura, K; Takano, H; Tang, XL; Xuan, YT1
Gross, GJ; Patel, HH; Peart, JN1
Gross, ER; Gross, GJ; Hsu, AK2

Other Studies

6 other study(ies) available for bw 373u86 and Cardiovascular Stroke

ArticleYear
Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats.
    Disease models & mechanisms, 2013, Volume: 6, Issue:2

    Topics: Animals; Benzamides; Cardiotonic Agents; Dietary Carbohydrates; Humans; In Vitro Techniques; Insulin; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Nitric Oxide Synthase; Obesity; Phosphorylation; Piperazines; Protein Kinases; Rats; Receptors, Opioid, delta; Signal Transduction; Thinness

2013
Delta opioid agonists and volatile anesthetics facilitate cardioprotection via potentiation of K(ATP) channel opening.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2002, Volume: 16, Issue:11

    Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Animals; Benzamides; Cardiotonic Agents; Diazoxide; Drug Synergism; Isoflurane; Models, Cardiovascular; Myocardial Infarction; Myocardium; Narcotics; Piperazines; Potassium Channels; Quinolines; Rats; Receptors, Opioid, delta

2002
Delta-opioid receptor-induced late preconditioning is mediated by cyclooxygenase-2 in conscious rabbits.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 283, Issue:5

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Benzamides; Benzylidene Compounds; Celecoxib; Consciousness; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Heart Rate; Ischemic Preconditioning, Myocardial; Isoenzymes; Male; Myocardial Infarction; Myocardial Stunning; Myocardium; Naltrexone; Narcotic Antagonists; Nitrobenzenes; Piperazines; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rabbits; Receptors, Opioid, delta; Sulfonamides

2002
Delta-opioid receptor activation mimics ischemic preconditioning in the canine heart.
    Journal of cardiovascular pharmacology, 2003, Volume: 42, Issue:1

    Topics: Animals; Benzamides; Disease Models, Animal; Dogs; Infusions, Intra-Arterial; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Piperazines; Quinolines; Receptors, Opioid, delta

2003
Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.
    Circulation research, 2004, Apr-16, Volume: 94, Issue:7

    Topics: Aminophenols; Androstadienes; Animals; Benzamides; Cardiotonic Agents; Chromones; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Indoles; Male; Maleimides; Morphine; Morpholines; Myocardial Infarction; Narcotic Antagonists; Nuclear Receptor Subfamily 1, Group F, Member 3; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Premedication; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Retinoic Acid; Receptors, Thyroid Hormone; Signal Transduction; Sirolimus; Wortmannin

2004
GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion.
    Basic research in cardiology, 2007, Volume: 102, Issue:4

    Topics: Analgesics, Opioid; Androstadienes; Animals; Benzamides; Benzopyrans; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Guanidines; Heart Rate; Imidazoles; Indoles; Ion Channel Gating; Male; Maleimides; Morphine; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Piperazines; Potassium Channel Blockers; Potassium Channels; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Sarcolemma; Signal Transduction; Time Factors; Wortmannin

2007